Skip to main content

Table 3 MANOVA and specific ANOVA showing influence of Iberian ibex captivity (t0 ibexes were in the wild, t1-t5 in the enclosure), and treatment (t2 and t3, before and after treatment, respectively) on physiological parameters (i.e., haematological parameters and acute phase protein concentration) and anti- C.pseudotuberculosis antibody presence (i.e., Optical Density (O.D.) obtained by means of ELISA) as a canonical response

From: Management of a caseous lymphadenitis outbreak in a new Iberian ibex (Capra pyrenaica) stock reservoir

MANOVA

Pillai’s trace

F-value

P-value

Early captivity (t0 vs t1)

0.974

15.793

0.001

Long-term captivity (t0 vs t1-t5)

0.818

10.284

3.468e-08

Treatment (t2 vs t3)

0.735

1.979

0.141

ANOVA

Mean ± SE (Min-Max)

F-value

P-value

Early captivity

   

IgG (O.D.)

 

37.993

6.352e-06

t0

0.22 ± 0.02 (0.16-0.4)

t1

0.5 ± 0.04 (0.22-0.7)

Leukocytes (×103 cells/μl)

 

5.338

0.032

t0

11.2 ± 1.33 (5.56-21.98)

t1

15.16 ± 0.86 (12.11-19.95)

Platelets (×103 cells/μl)

 

6.652

0.018

t0

260.82 ± 52.41 (46–563)

t1

470.55 ± 58.3 (109–784)

Monocytes (×103 cells/μl)

 

7.370

0.014

t0

2.16 ± 0.58 (0.6-6.2)

t1

0.59 ± 0.15 (0.2-2)

Eosinphils (×103 cells/μl)

 

5.085

0.036

t0

3.13 ± 0.67 (1–8.4)

t1

5.08 ± 0.72 (1.8-10)

Basophils (×103 cells/μl)

 

10.604

0.004

t0

1.76 ± 0.37 (0.6-5.2)

t1

0.59 ± 0.05 (0.4-1)

Total Protein (g/dl)

 

15.952

0.001

t0

7.1 ± 0.13 (6.4-7.9)

t1

8.31 ± 0.27 (7–9.6)

Long-term captivity

   

IgG (O.D.)

 

10.432

0.002

t0

0.23 ± 0.03 (0.17-0.4)

t1-t5

0.48 ± 0.03 (0.196-1.37)

Basophils (×103 cells/μl)

 

56.797

1.644e-09

t0

1.38 ± 0.13 (0.6-1.7)

t1-t5

0.61 ± 0.04 (0.2-1.2)

Treatment

   

Haemoglobin (g/dl)

 

4.689

0.041

t2

10.46 ± 0.46 (7.7-13.2)

t3

11.92 ± 0.49 (8.6-13.6)

PCV (%)

 

5.061

0.034

t2

33.25 ± 1.54 (24.5-42.7)

t3

38.33 ± 1.65 (27.4-44.8)

  1. ANOVA values illustrate statistically significant parameters associated with captivity and treatment effect.